The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Soy isoflavones and prostate cancer: A review of molecular mechanisms
Open accessAbstract
Soy isoflavones are dietary components for which an association has been demonstrated with reduced risk of prostate cancer (PCa) in Asian populations. However, the exact mechanism by which these isoflavones may prevent the development or progression of PCa is not completely understood. There are a growing number of animal and in vitro studies that have attempted to elucidate these mechanisms. The predominant and most biologically active isoflavones in soy products, genistein, daidzein, equol, and glycetin, inhibit prostate carcinogenesis in some animal models. Cell-based studies show that soy isoflavones regulate genes that control cell cycle and apoptosis. In this review, we discuss the literature relevant to the molecular events that may account for the benefit of soy isoflavones in PCa prevention or treatment. These reports show that although soy isoflavone-induced growth arrest and apoptosis of PCa cells are plausible mechanisms, other chemo protective mechanisms are also worthy of consideration. These possible mechanisms include antioxidant defense, DNA repair, inhibition of angiogenesis and metastasis, potentiation of radio- and chemotherapeutic agents, and antagonism of estrogen- and androgen-mediated signaling pathways. Moreover, other cells in the cancer milieu, such as the fibroblastic stromal cells, endothelial cells, and immune cells, may be targeted by soy isoflavones, which may contribute to soy-mediated prostate cancer prevention. In this review, these mechanisms are discussed along with considerations about the doses and the preclinical models that have been used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Kikuno, N., Shiina, H., Urakami, S., Kawamoto, K., Hirata, H., Tanaka, Y., Majid, S., Igawa, M., & Dahiya, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23590 · Cited by 219
RetractedLi, Y., Küçük, Ö., Hussain, M., Abrams, J., Cher, M. L., & Sarkar, F. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3752 · Cited by 119
RetractedRaffoul, J. J., Banerjee, S., Singh‐Gupta, V., Knoll, Z. E., Fite, A., Zhang, H., Abrams, J., Sarkar, F. H., & Hillman, G. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2147 · Cited by 104
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09408-4 · Cited by 1,686
Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks
Alers, S., Löffler, A. S., Wesselborg, S., & Stork, B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06159-11 · Cited by 1,483
Yost, C., Torres, M., Miller, J. R., Huang, E., Kimelman, D., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.12.1443 · Cited by 1,165
Craft, N., Shostak, Y., Carey, M., & Sawyers, C. L. (1999) · Nature Medicine · doi:10.1038/6495 · Cited by 980
Patrawala, L., Calhoun, T., Schneider-Broussard, R., Li, H., Bhatia, B., Tang, S., Reilly, J. G., Chandra, D., Zhou, J., Claypool, K., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209327 · Cited by 968
A luminal epithelial stem cell that is a cell of origin for prostate cancer
Wang, X., Julio, M. K.-D., Economides, K. D., Walker, D., Yu, H., Halili, M. V., Hu, Y.-P., Price, S. M., Abate-Shen, C., & Shen, M. M. (2009) · Nature · doi:10.1038/nature08361 · Cited by 734
Plasma concentrations of phyto-oestrogens in Japanese men
ADLERCREUTZ, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92188-y · Cited by 731
Koivisto, P. A., Kononen, J., Palmberg, C., Tammela, T. L. J., HYYTINEN, E.-R., Isola, J. J., Trapman, J., Cleutjens, K. B. J. M., Noordzij, M. A., Visakorpi, T., et al. (1997) · PubMed · Cited by 728
Gregory, C. W., He, B., Johnson, R. T., Ford, O. H., Mohler, J. L., French, F. S., & Wilson, E. M. (2001) · PubMed · Cited by 708
Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA..
MORITO, K., HIROSE, T., KINJO, J., HIRAKAWA, T., OKAWA, M., NOHARA, T., OGAWA, S., INOUE, S., MURAMATSU, M., & MASAMUNE, Y. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.351 · Cited by 614
Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise
Khan, N., Afaq, F., & Mukhtar, H. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1740 · Cited by 591
Mechanisms of Androgen-Refractory Prostate Cancer
Debes, J. D., & Tindall, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048178 · Cited by 558
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
Grossmann, M. E., Huang, H., & Tindall, D. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1687 · Cited by 548
Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells
Montgomery, R. K., Carlone, D. L., Richmond, C. A., Farilla, L., Kranendonk, M. E. G., Henderson, D. E., Baffour-Awuah, N. Y., Ambruzs, D. M., Fogli, L. K., Algra, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013004108 · Cited by 540
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
Catto, J. W. F., Alcaraz, A., Bjartell, A. S., De Vere White, R., Evans, C. P., Fussel, S., Hamdy, F. C., Kallioniemi, O., Mengual, L., Schlomm, T., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.01.044 · Cited by 469
Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA.(II).
Morito, K., Aomori, T., Hirose, T., Kinjo, J., Hasegawa, J., Ogawa, S., Inoue, S., Muramatsu, M., & Masamune, Y. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.48 · Cited by 464
Antioxidant Activity of Phytoestrogenic Isoflavones
Ruiz-Larrea, M. B., Mohan, A. R., Paganga, G., Miller, N. J., Bolwell, G. P., & Rice-Evans, C. A. (1997) · Free Radical Research · doi:10.3109/10715769709097785 · Cited by 463
A role for estrogen receptor β in the regulation of growth of the ventral prostate
Weihua, Z., Mäkelä, S., Andersson, L. C., Salmi, S., Saji, S., Webster, J. I., Jensen, E. V., Nilsson, S., Warner, M., & Gustafsson, J.-Å. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111150898 · Cited by 440
Generation of a prostate from a single adult stem cell
Leong, K. G., Wang, B.-E., Johnson, L., & Gao, W.-Q. (2008) · Nature · doi:10.1038/nature07427 · Cited by 421
Fang, M. Z., Chen, D., Sun, Y., Jin, Z., Christman, J. K., & Yang, C. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0406 · Cited by 410
Leav, I., Lau, K.-M., Adams, J. Y., McNeal, J. E., Taplin, M.-E., Wang, J., Singh, H., & Ho, S.-M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61676-8 · Cited by 394
Roy, S. K., Srivastava, R. K., & Shankar, S. (2010) · Journal of Molecular Signaling · doi:10.1186/1750-2187-5-10 · Cited by 379
Graff, J. R., Konicek, B. W., McNulty, A. M., Wang, Z., Houck, K., Allen, S., Paul, J. D., Hbaiu, A., Goode, R. G., Sandusky, G. E., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003145200 · Cited by 378
Inoue, K., Slaton, J. W., Eve, B. Y., Kim, S. J., Perrotte, P., Balbay, M. D., Yano, S., Bar‐Eli, M., Radinsky, R., Pettaway, C. A., et al. (2000) · PubMed · Cited by 361
English, H. F., Santen, R. J., & Lsaacs, J. T. (1987) · The Prostate · doi:10.1002/pros.2990110304 · Cited by 354
Zhou, J.-R., Gugger, E. T., Tanaka, T., Guo, Y., Blackburn, G. L., & Clinton, S. K. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.9.1628 · Cited by 343
Kreisberg, J. I., Malik, S. N., Prihoda, T. J., Bedolla, R. G., Troyer, D. A., Kreisberg, S., & Ghosh, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0272 · Cited by 324
IGF-I receptor signalling in transformation and differentiation
Valentinis, B., & Baserga, R. (2001) · Molecular Pathology · doi:10.1136/mp.54.3.133 · Cited by 323
An, J., Tzagarakis-Foster, C., Scharschmidt, T. C., Lomri, N., & Leitman, D. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100953200 · Cited by 323
Setchell, K. D., Faughnan, M. S., Avades, T., Zimmer-Nechemias, L., Brown, N. M., Wolfe, B. E., Brashear, W. T., Desai, P., Oldfield, M. F., Botting, N. P., et al. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.411 · Cited by 320
Cancer stem cells: problems for therapy?
Alison, M. R., Lim, S. M., & Nicholson, L. J. (2011) · The Journal of Pathology · doi:10.1002/path.2793 · Cited by 312
Li, Y., & Sarkar, F. H. (2002) · PubMed · Cited by 298
Joannou, G. E., Kelly, G. E., Reeder, A. Y., Waring, M., & Nelson, C. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00131-i · Cited by 282
Agarwal, R. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00385-3 · Cited by 280
Klein, C. A. (2008) · Science · doi:10.1126/science.1164853 · Cited by 272
Murillo, H. (2001) · Endocrinology · doi:10.1210/en.142.11.4795 · Cited by 263
Osteopontin: possible role in prostate cancer progression.
Thalmann, G. N., Sikes, R. A., Devoll, R. E., Kiefer, J., Markwalder, R. V., Klima, I., Farach‐Carson, M. C., Studer, U. E., & Chung, L. W. K. (1999) · PubMed · Cited by 261
Chen, T., Wang, L. H., & Farrar, W. L. (2000) · PubMed · Cited by 258
Genistein Inhibits NF-kB Activation in Prostate Cancer Cells
Davis, J. N., Kucuk, O., & Sarkar, F. H. (1999) · Nutrition and Cancer · doi:10.1207/s15327914nc352_11 · Cited by 250
Mentor-Marcel, R. A., Lamartiniere, C. A., Eltoum, I.-E. A., Greenberg, N. M., & Elgavish, A. (2001) · PubMed · Cited by 249
EFFECT OF ORCHIECTOMY AND IRRADIATION ON CANCER OF THE PROSTATE
Huggins, C. (1942) · Annals of Surgery · doi:10.1097/00000658-194206000-00030 · Cited by 244
Morton, M. S., Chan, P. S. F., Cheng, C., Blacklock, N., Matos-Ferreira, A., Abranches-Monteiro, L., Correia, R., Llyod, S., & Griffiths, K. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970701)32:2<122::aid-pros7>3.0.co;2-o · Cited by 244
Estrogen Receptor Expression in Prostate Cancer and Premalignant Prostatic Lesions
Bonkhoff, H., Fixemer, T., Hunsicker, I., & Remberger, K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65160-7 · Cited by 238
Cyclooxygenase-2 and prostate carcinogenesis
Hussain, T., Gupta, S., & Mukhtar, H. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00524-4 · Cited by 237
Polyphenols: Skin Photoprotection and Inhibition of Photocarcinogenesis
Afaq, F., & K. Katiyar, S. (2011) · Mini Reviews in Medicinal Chemistry · doi:10.2174/138955711804586739 · Cited by 234
Soy Food Consumption and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
Hwang, Y. W., Kim, S. Y., Jee, S. H., Kim, Y. N., & Nam, C. M. (2009) · Nutrition and Cancer · doi:10.1080/01635580902825639 · Cited by 234
Celecoxib: A Specific COX-2 Inhibitor with Anticancer Properties
Koki, A. T., & Masferrer, J. L. (2002) · Cancer Control · doi:10.1177/107327480200902s04 · Cited by 233
Prostate cancer stem/progenitor cells: Identification, characterization, and implications
Tang, D. G., Patrawala, L., Calhoun, T., Bhatia, B., Choy, G., Schneider‐Broussard, R., & Jeter, C. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20255 · Cited by 223
Huang, X., Chen, S., Xu, L., Liu, Y., Deb, D. K., Platanias, L. C., & Bergan, R. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2807 · Cited by 215
Xu, L., Chen, S., & Bergan, R. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209337 · Cited by 213
Ricke, W. A., McPherson, S. J., Bianco, J. J., Cunha, G. R., Wang, Y., & Risbridger, G. P. (2008) · The FASEB Journal · doi:10.1096/fj.07-9526com · Cited by 213
Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate
Imamov, O., Morani, A., Shim, G.-J., Omoto, Y., Thulin-Andersson, C., Warner, M., & Gustafsson, J.-Å. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403041101 · Cited by 208
Fixemer, T., Remberger, K., & Bonkhoff, H. (2003) · The Prostate · doi:10.1002/pros.10171 · Cited by 208
Zhu, X., Leav, I., Leung, Y.-K., Wu, M., Liu, Q., Gao, Y., McNeal, J. E., & Ho, S.-M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63760-1 · Cited by 205
Raffoul, J. J., Wang, Y., Kucuk, O., Forman, J. D., Sarkar, F. H., & Hillman, G. G. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-107 · Cited by 203
Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.
Fosslien, E. (2001) · PubMed · Cited by 200
McPherson, S. J., Hussain, S., Balanathan, P., Hedwards, S. L., Niranjan, B., Grant, M., Chandrasiri, U. P., Toivanen, R., Wang, Y., Taylor, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905524107 · Cited by 197
Prostaglandin endoperoxide synthases-1 and -2
Otto, J. C., & Smith, W. L. (1995) · Journal of Lipid Mediators and Cell Signalling · doi:10.1016/0929-7855(95)00015-i · Cited by 194
A brief introduction to FOXOlogy
Burgering, B. M. T. (2008) · Oncogene · doi:10.1038/onc.2008.29 · Cited by 194
Suzuki, K., Koike, H., Matsui, H., Ono, Y., Hasumi, M., Nakazato, H., Okugi, H., Sekine, Y., Oki, K., Ito, K., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10428 · Cited by 184
Majid, S., Dar, A. A., Shahryari, V., Hirata, H., Ahmad, A., Saini, S., Tanaka, Y., Dahiya, A. V., & Dahiya, R. (2010) · Cancer · doi:10.1002/cncr.24662 · Cited by 183
Bloedon, L. T., Jeffcoat, A. R., Lopaczynski, W., Schell, M. J., Black, T. M., Dix, K. J., Thomas, B. F., Albright, C., Busby, M. G., Crowell, J. A., et al. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1126 · Cited by 182
Price, D., Stein, B., Sieber, P., Tutrone, R., Bailen, J., Goluboff, E., Burzon, D., Bostwick, D., Steiner, M., & GTx-006-221 Study Team (2006) · Journal of Urology · doi:10.1016/j.juro.2006.04.011 · Cited by 172
Diet, Autophagy, and Cancer: A Review
Singletary, K. W., & Milner, J. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2917 · Cited by 172
Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice
Lakshman, M., Xu, L., Ananthanarayanan, V., Cooper, J., Takimoto, C. H., Helenowski, I., Pelling, J. C., & Bergan, R. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1246 · Cited by 170
Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate
Fritz, W. A., Wang, J., Eltoum, I.-E., & Lamartiniere, C. A. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00663-3 · Cited by 169
Kazi, A., Daniel, K. G., Smith, D. M., Kumar, N. B., & Dou, Q. P. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00414-3 · Cited by 168
Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells
GOSSNER, G., CHOI, M., TAN, L., FOGOROS, S., GRIFFITH, K., KUENKER, M., & LIU, J. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.11.009 · Cited by 166
Lazarevic, B., Boezelijn, G., Diep, L. M., Kvernrød, K., Øgren, O., Ramberg, H., Moen, A. R., Wessel, N., Berg, R. E., Egge-Jacobsen, W. M., et al. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.582221 · Cited by 159
Androgen receptor action in hormone‐dependent and recurrent prostate cancer
Agoulnik, I. U., & Weigel, N. L. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20811 · Cited by 156
Dalais, F. S., Meliala, A., Wattanapenpaiboon, N., Frydenberg, M., Suter, D. A. I., Thomson, W. K., & Wahlqvist, M. L. (2004) · Urology · doi:10.1016/j.urology.2004.04.009 · Cited by 155
Soy Isoflavones in the Treatment of Prostate Cancer
Hussain, M., Banerjee, M., Sarkar, F. H., Djurić, Z., Pollak, M., Doerge, D. R., Fontana, J. A., Chinni, S. R., Davis, J. N., Forman, J. D., et al. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4702_1 · Cited by 154
Insulin-Like Growth Factor (IGF) family and prostate cancer
Gennigens, C., Ménétrier‐Caux, C., & Droz, J. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.10.003 · Cited by 152
The specific role of isoflavones in reducing prostate cancer risk
Kumar, N. B., Cantor, A. B., Allen, K., Riccardi, D., Besterman‐Dahan, K., Seigne, J. D., Helal, M. M., Salup, R. R., & Pow‐Sang, J. M. (2003) · The Prostate · doi:10.1002/pros.10362 · Cited by 152
Werner, H., & Roith*, D. L. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000735 · Cited by 149
Nakamura, Y., Yogosawa, S., Izutani, Y., Watanabe, H., Otsuji, E., & Sakai, T. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-100 · Cited by 149
Kimura, T. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10324 · Cited by 144
Wang, S., DeGroff, V. L., & Clinton, S. K. (2003) · Journal of Nutrition · doi:10.1093/jn/133.7.2367 · Cited by 143
Hedlund, T. E., Johannes, W. U., & Miller, G. J. (2002) · The Prostate · doi:10.1002/pros.10137 · Cited by 142
Expression of Androgen Receptor Coregulators in Prostate Cancer
Linja, M. J., Porkka, K. P., Kang, Z., Savinainen, K., Jänne, O. A., Tammela, T. L. J., Vessella, R. L., Palvimo, J. J., & Visakorpi, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0990-3 · Cited by 141
Xu, J., Wang, R., Xie, Z. H., Odero‐Marah, V., Pathak, S., Multani, A. S., Chung, L. W. K., & Zhau, H. E. (2006) · The Prostate · doi:10.1002/pros.20488 · Cited by 140
Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer
Li, P., Yu, X., Ge, K., Melamed, J., Roeder, R. G., & Wang, Z. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64422-7 · Cited by 137
Estrogen receptor-?: Implications for the prostate gland
Chang, W. Y., & Prins, G. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990701)40:2<115::aid-pros7>3.0.co;2-3 · Cited by 135
Seibel, J., Molzberger, A. F., Hertrampf, T., Laudenbach-Leschowsky, U., & Diel, P. R. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0004-3 · Cited by 132
Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function
Basak, S., Pookot, D., Noonan, E. J., & Dahiya, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0617 · Cited by 132
Takimoto, C. H. M., Glover-Cutter, K. M., Huang, X., Hayes, S. A., Gallot, L., Quinn, M. G., Jovanovic, B. D., Shapiro, A., Hernandez, L., Goetz, A. D., et al. (2003) · PubMed · Cited by 129
Ji, G., Yang, Q., Hao, J., Guo, L., Chen, X., Hu, J., Leng, L., & Jiang, Z. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.036 · Cited by 129
Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer
White, R. D., Hackman, R. M., Soares, S., Beckett, L. A., Li, Y., & Sun, B. (2004) · Urology · doi:10.1016/j.urology.2003.09.061 · Cited by 126
Pines, A., Perrone, L., Bivi, N., Romanello, M., Damante, G., Gulisano, M., Kelley, M., Quadrifoglio, F., & Tell, G. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki751 · Cited by 126
Regulation of Akt/FOXO3a/GSK-3β/AR Signaling Network by Isoflavone in Prostate Cancer Cells
Li, Y., Wang, Z. P., Kong, D., Li, R., Sarkar, S. H., & Sarkar, F. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802759200 · Cited by 125
Moiseeva, E. P., Almeida, G. M., Jones, G. D. D., & Manson, M. M. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0117 · Cited by 125
Bektić, J., Berger, A. P., Pfeil, K., Dobler, G., Bartsch, G. H., & Klocker, H. (2003) · European Urology · doi:10.1016/j.eururo.2003.09.001 · Cited by 124
Valentinis, B., Romano, G., Peruzzi, F., Morrione, A., di Prisco, M., Soddu, S., Cristofanelli, B., Sacchi, A., & Baserga, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12423 · Cited by 124
Vardi, A., Bosviel, R., Rabiau, N., Adjakly, M., Satih, S., Dechelotte, P., Boiteux, J., Fontana, L., Bignon, Y., Guy, L., et al. (2010) · PubMed · Cited by 123
Uzgare, A. R., & Isaacs, J. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0968 · Cited by 121
Pendleton, J. M., Tan, W. W., Anai, S., Chang, M. N., Hou, W., Shiverick, K. T., & Rosser, C. J. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-132 · Cited by 118
Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes
Foti, P., Erba, D., Riso, P., Spadafranca, A., Criscuoli, F., & Testolin, G. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.10.008 · Cited by 118
Shen, J. P. Y.-C., Klein, R. D., Wei, Q., Guan, Y., Contois, J. H., Wang, T. T. Y., Chang, S., & Hursting, S. D. (2000) · Molecular Carcinogenesis · Cited by 117
Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model
Hillman, G. G., Wang, Y., Küçük, Ö., Che, M., Doerge, D. R., Yudelev, M., Joiner, M. C., Marples, B., Forman, J. D., & Sarkar, F. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1271.3.10 · Cited by 117
Macrophage Role in the Anti-Prostate Cancer Response to One Class of Antiangiogenic Agents
Joseph, I. B. J., & Isaacs, J. T. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1648 · Cited by 116
Yu, X., Zhu, J., Mi, M., Chen, W., Pan, Q., & Wei, M. (2010) · Medical Oncology · doi:10.1007/s12032-010-9770-2 · Cited by 113
Guo, Y., Wang, S., Hoot, D. R., & Clinton, S. K. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.08.006 · Cited by 113
Gene Expression Profiles of Genistein-Treated PC3 Prostate Cancer Cells
Li, Y., & Sarkar, F. H. (2002) · Journal of Nutrition · doi:10.1093/jn/132.12.3623 · Cited by 112
Urban, D. A., Irwin, W., KIRK, M., Markiewicz, M. A., MYERS, R., SMITH, M., Weiss, H. L., Grizzle, W. E., & Barnes, S. (2001) · The Journal of Urology · doi:10.1097/00005392-200101000-00082 · Cited by 110
Park, C.-E., Yun, H., Lee, E.-B., Min, B.-I., Bae, H., Choe, W., Kang, I., Kim, S. S., & Ha, J. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.1359 · Cited by 109
Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression
Jones, E., Pu, H., & Kyprianou, N. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802705696 · Cited by 109
Li, Y., Kong, D., Ahmad, A., Bao, B., Dyson, G. E., & Sarkar, F. H. (2012) · Epigenetics · doi:10.4161/epi.21236 · Cited by 106
Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein.
Li, Y., Bhuiyan, M., & Sarkar, F. H. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.3.525 · Cited by 105
Gao, S., Liu, G., & Wang, Z. (2003) · The Prostate · doi:10.1002/pros.10375 · Cited by 104
Zhao, L., Mao, Z., & Brinton, R. D. (2008) · Endocrinology · doi:10.1210/en.2008-0715 · Cited by 104
Touny, L. H. E., & Banerjee, P. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2958 · Cited by 103
Dietary phytoestrogens: A possible role in renal disease protection
Velasquez, M. T., & Bhathena, S. J. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(05)80025-3 · Cited by 102
Aberrant expression of E-cadherin and beta-catenin in human prostate cancer☆
Jaggi, M., Johansson, S. L., Baker, J. J., Smith, L. M., Galich, A., & Balaji, K. C. (2005) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.03.024 · Cited by 101
Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells
Hsu, A., Bray, T. Μ., Helferich, W. G., Doerge, D. R., & Ho, E. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009128 · Cited by 101
Uehara, H., Troncoso, P., Johnston, D. A., Bucana, C. D., Dinney, C. P., Dong, Z., Fidler, I. J., & Pettaway, C. A. (2005) · The Prostate · doi:10.1002/pros.20223 · Cited by 99
Singh‐Gupta, V., Zhang, H., Banerjee, S., Kong, D., Raffoul, J. J., Sarkar, F. H., & Hillman, G. G. (2008) · International Journal of Cancer · doi:10.1002/ijc.24015 · Cited by 98
Grainger, E. M., Schwartz, S. J., Wang, S., Unlu, N. Z., Boileau, T. W.-M., Ferketich, A. K., Monk, J. P., Gong, M., Bahnson, R. R., DeGroff, V. L., et al. (2008) · Nutrition and Cancer · doi:10.1080/01635580701621338 · Cited by 95
The role of prostaglandin synthesis in prostate cancer
Badawi, A. F. (2000) · British Journal of Urology · doi:10.1046/j.1464-410x.2000.00507.x · Cited by 93
Xu, L., & Bergan, R. C. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023861 · Cited by 89
Genistein potentiates the radiation effect on prostate carcinoma cells.
Hillman, G. G., Forman, J. D., Kucuk, O., Yudelev, M., Maughan, R. L., Rubio, J., Layer, A., Tekyi‐Mensah, S., Abrams, J., & Sarkar, F. H. (2001) · PubMed · Cited by 88
White, R. D., Tsodikov, A. D., Stapp, E. C., Soares, S., Fujii, H., & Hackman, R. M. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.492085 · Cited by 88
Raschke, M., Rowland, I. R., Magee, P. J., & Pool-Zobel, B. L. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl082 · Cited by 87
Human Androgen Receptor Binding to the Androgen Response Element of Prostate Specific Antigen
Luke, M. C., & Coffey, D. S. (1994) · Journal of Andrology · doi:10.1002/j.1939-4640.1994.tb01682.x · Cited by 86
Genistein chemoprevention of prostate cancer in TRAMP mice
Wang, J., Eltoum, I.-E. A., & Lamartiniere, C. A. (2007) · Journal of Carcinogenesis · doi:10.1186/1477-3163-6-3 · Cited by 86
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model
Raffoul, J. J., Banerjee, S., Che, M., Knoll, Z. E., Doerge, D. R., Abrams, J., Küçük, Ö., Sarkar, F. H., & Hillman, G. G. (2007) · International Journal of Cancer · doi:10.1002/ijc.22548 · Cited by 85
Zhou, J., Yu, L., Zhong, Y., Nassr, R. L., Franke, A. A., Gaston, S. M., & Blackburn, G. L. (2002) · The Prostate · doi:10.1002/pros.10141 · Cited by 84
E-cadherin and α-, β- and γ-catenin expression in prostate cancers: correlation with tumour invasion
Morita, N., Uemura, H., Tsumatani, K., Cho, M., Hirao, Y., Okajima, E., Konishi, N., & Hiasa, Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690299 · Cited by 82
Ouchi, H., Ishiguro, H., IKEDA, N., Hori, M., Kubota, Y., & Uemura, H. (2005) · International Journal of Urology · doi:10.1111/j.1442-2042.2004.00973.x · Cited by 82
Hong, S. J., Kim, S. I., Kwon, S. M., Lee, J. R., & Chung, B. C. (2002) · Yonsei Medical Journal · doi:10.3349/ymj.2002.43.2.236 · Cited by 82
Swami, S., Krishnan, A. V., Moreno, J., Bhattacharyya, R. S., Gardner, C. D., Brooks, J. D., Peehl, D. M., & Feldman, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.24161 · Cited by 81
Hamilton‐Reeves, J. M., Rebello, S. A., Thomas, W. T. B., Slaton, J. W., & Kurzer, M. S. (2007) · Journal of Nutrition · doi:10.1093/jn/137.7.1769 · Cited by 81
Davis, J. N., Küçük, Ö., & Sarkar, F. H. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10053 · Cited by 79
Hyperacetylated Chromatin Domains: Lessons from Heterochromatin
Bulger, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r500004200 · Cited by 77
Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation
Gardner, C. D., Oelrich, B., Liu, J. P., Feldman, D., Franke, A. A., & Brooks, J. D. (2009) · The Prostate · doi:10.1002/pros.20922 · Cited by 75
Bosland, M. C., Kato, I., Zeleniuch‐Jacquotte, A., Schmoll, J., Enk, E., Melamed, J., Kong, M. X., Macias, V., Kajdacsy‐Balla, A., Lumey, L. H., et al. (2013) · JAMA · doi:10.1001/jama.2013.7842 · Cited by 74
Self-citationAdjakly, M., Bosviel, R., Rabiau, N., Boiteux, J., Bignon, Y., Guy, L., & Bernard-Gallon, D. J. (2011) · Epigenomics · doi:10.2217/epi.11.103 · Cited by 74
Kumi-Diaka, J. K., Sanderson, N., & Hall, A. (2000) · Biology of the Cell · doi:10.1016/s0248-4900(00)01109-6 · Cited by 72
Mentor-Marcel, R. A., Lamartiniere, C. A., Eltoum, I. A., Greenberg, N. M., & Elgavish, A. (2005) · Journal of Nutrition · doi:10.1093/jn/135.5.989 · Cited by 71
Handayani, R., Rice, L. P., Cui, Y., Medrano, T. A., Samedi, V. G., Baker, H. V., Szabo, N. J., & Shiverick, K. T. (2006) · Journal of Nutrition · doi:10.1093/jn/136.1.75 · Cited by 70
Özkan, E. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.002 · Cited by 67
The role of estrogens in prostate carcinogenesis: a rationale for chemoprevention.
Bosland, M. C. (2005) · Europe PMC (PubMed Central) · Cited by 63
Self-citationBarclay, W. W., Axanova, L. S., Chen, W., Romero, L. M., Maund, S. L., Söker, S., Lees, C. J., & Cramer, S. D. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0309 · Cited by 62
Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer
Gallego, G. A., Díaz‐Prado, S., Fonseca, P. J., Campelo, R. G., Espinosa, J., & Aparicio, L. M. A. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0126-0 · Cited by 62
Swami, S., Krishnan, A. V., Moreno, J., Bhattacharyya, R. S., Peehl, D. M., & Feldman, D. (2007) · Journal of Nutrition · doi:10.1093/jn/137.1.205s · Cited by 61
Mahmoud, A. M., Zhu, T., Parray, A., Siddique, H. R., Yang, W., Saleem, M., & Bosland, M. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078479 · Cited by 59
Self-citationTakahashi, Y., Lavigne, J. A., Hursting, S. D., Chandramouli, G. V. R., Perkins, S. N., Barrett, J. C., & Wang, T. T. Y. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20045 · Cited by 56
Jenkins, D., Kendall, C. W. C., D’Costa, M., Jackson, C. C., Vidgen, E., Singer, W., Silverman, J. A., Koumbridis, G., HONEY, J., RAO, A. V., et al. (2003) · The Journal of Urology · doi:10.1016/s0022-5347(05)63944-4 · Cited by 52
Touny, L. H. E., & Banerjee, P. P. (2006) · The Prostate · doi:10.1002/pros.20495 · Cited by 51
Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP
Payton‐Stewart, F., Schoene, N. W., Kim, Y. S., Burow, M. E., Cleveland, T. E., Boué, S. M., & Wang, T. T. Y. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20532 · Cited by 51
Bouchal, J., Santer, F. R., Höschele, P. P. S., Tomaštíková, E. D., Neuwirt, H., & Čulig, Z. (2010) · The Prostate · doi:10.1002/pros.21257 · Cited by 50
Hamilton‐Reeves, J. M., Rebello, S. A., Thomas, W. B., Kurzer, M. S., & Slaton, J. W. (2007) · Nutrition and Cancer · doi:10.1080/01635580701586770 · Cited by 49
Jenkins, D., Kendall, C. W. C., D’Costa, M., et al. (2003) · PubMed · doi:10.1097/01.ju.0000046060.59113.57 · Cited by 48
Oh, H. Y., Leem, J., Yoon, S. J., Yoon, S. O., & Hong, S. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.133 · Cited by 48
Oki, T., Sowa, Y., Hirose, T., Takagaki, N., Horinaka, M., Nakanishi, R., Yasuda, C., Yoshida, T., Kanazawa, M., Satomi, Y., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.085 · Cited by 47
Wang, B. F., Wang, J. S., Lu, J., Kao, T. H., & Chen, B. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8037715 · Cited by 46
Maggiolini, M., Vivacqua, A., Carpino, A., Bonofiglio, D., Fasanella, G., Salerno, M., Picard, D., & Andò, S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1027 · Cited by 46
Ambra, R., Rimbach, G. H., de Pascual‐Teresa, S., Fuchs, D., Wenzel, U., Daniel, H., & Virgili, F. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.03.003 · Cited by 45
miRNAs differentially expressed in prostate cancer cell lines after soy treatment.
Rabiau, N., Trraf, H.-K., Adjakly, M., Bosviel, R., Guy, L., Fontana, L., Bignon, Y., & Bernard-Gallon, D. J. (2011) · PubMed · Cited by 45
McCubrey, J. A., Abrams, S. L., Stadelman, K. M., Chappell, W. H., LaHair, M. M., Ferland, R. A., & Steelman, L. S. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.016 · Cited by 44
Liu, Y., Kyle, E., Lieberman, R., Crowell, J. A., Gj, K., & Bergan, R. C. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1006729106034 · Cited by 40
Iwasaki, M., Hamada, G. S., Nishimoto, I. N., Netto, M. M., Mottola, J., Laginha, F. M., Kasuga, Y., Yokoyama, S., Onuma, H., Nishimura, H., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01118.x · Cited by 40
Maskarinec, G., Morimoto, Y., Hebshi, S. M., Sharma, S., Franke, A. A., & Stanczyk, F. Z. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602473 · Cited by 40
Influence of Genistein Isoflavone on Matrix Metalloproteinase-2 Expression in Prostate Cancer Cells
Kumi-Diaka, J. K., Hassanhi, M., Merchant, K., & Hörmann, V. (2006) · Journal of Medicinal Food · doi:10.1089/jmf.2006.9.491 · Cited by 38
Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
Cao, F., Jin, T.-Y., & Zhou, Y.-F. (2006) · PubMed · Cited by 37
Vinall, R. L., Hwa, K., Ghosh, P., Pan, C.-X., Lara, P. N., & White, R. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0600 · Cited by 36
Napora, J. K., Short, R. G., Muller, D. C., Carlson, O. D., Odetunde, J. O., Xu, X., Carducci, M., Travison, T. G., Maggio, M., Egan, J. M., et al. (2011) · Journal of Andrology · doi:10.2164/jandrol.110.010983 · Cited by 35
Genetic and epigenetic regulations of prostate cancer by genistein
Molinié, B., & Georgel, P. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.5.1378633 · Cited by 35
Kwan, W., Duncan, G. G., Patten, C. L. V., Liu, M., & Lim, J. T. W. (2010) · Nutrition and Cancer · doi:10.1080/01635580903305318 · Cited by 34
Tepper, C. G., Vinall, R. L., Wee, C. B., Xue, L., Shi, X.-B., Burich, R. A., Mack, P. C., & White, R. D. (2007) · The Prostate · doi:10.1002/pros.20548 · Cited by 34
Pugalendhi, P., Manoharan, S., Kuppusamy, P., et al. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70035-0 · Cited by 32
Genistein inhibits the contact-stimulated migration of prostate cancer cells
Miękus, K., & Madeja, Z. (2007) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-007-0007-0 · Cited by 32
Takahashi, Y. K., Lavigne, J. A., Hursting, S. D., Chandramouli, G. V. R., Perkins, S. N., Kim, Y. S., & Wang, T. T. Y. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20247 · Cited by 29
Hermann, R. M., Wolff, H. A., Jarry, H., Thelen, P., Gründker, C., Rave‐Fränk, M., Schmidberger, H., & Christiansen, H. (2008) · Radiation Oncology · doi:10.1186/1748-717x-3-19 · Cited by 29
Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth
Ping, S., Hour, T., Lin, S., & Yü, D. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.07.003 · Cited by 25
Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer.
Liss, M. A., Schlicht, M. J., Kahler, A., Fitzgerald, R. T., Thomassi, T., DeGueme, A. M., Hessner, M., & Datta, M. W. (2010) · PubMed · Cited by 25
TGF-β signalling and immunity in prostate tumourigenesis
Diener, K. R., Need, E. F., Buchanan, G., & Hayball, J. D. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903544507 · Cited by 24
Burich, R. A., Holland, W. S., Vinall, R. L., Tepper, C. G., White, R. D., & Mack, P. C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07826.x · Cited by 23
Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer
Christensen, M. J., Quiner, T. E., Nakken, H. L., Lephart, E. D., Eggett, D. L., & Urie, P. M. (2013) · The Prostate · doi:10.1002/pros.22646 · Cited by 18
Targeting the cancer initiating cell: The Achilles’ heel of cancer
McCubrey, J. A., Chappell, W. H., Abrams, S. L., Franklin, R. A., Long, J. M., Sattler, J. A., Kempf, C., Laidler, P. M., & Steelman, L. S. (2010) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2010.09.002 · Cited by 15
Skogseth, H., Follestad, T., LARSSON, E., & Halgunset, J. (2006) · Apmis · doi:10.1111/j.1600-0463.2006.apm_370.x · Cited by 13
Cited by
Important Flavonoids and Their Role as a Therapeutic Agent
Ullah, A., Munir, S., Badshah, S. L., Khan, N., Ghani, L., Poulson, B. G., Emwas, A.-H., & Jaremko, M. (2020) · Molecules · doi:10.3390/molecules25225243 · Cited by 1,696
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
The gut microbiota: a key factor in the therapeutic effects of (poly)phenols
Espín, J. C., González-Sarrías, A., & Tomás-Barberán, F. A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.033 · Cited by 603
Mayo, B., Vázquez, L., & Flórez, A. B. (2019) · Nutrients · doi:10.3390/nu11092231 · Cited by 416
Zaheer, K., & Humayoun Akhtar, M. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.989958 · Cited by 411
Metadata
- Authors
- Mahmoud, A. M., Yang, W., & Bosland, M. C.
- Venue
- The Journal of Steroid Biochemistry and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 140
- Pages
- 116-132
- ISSN
- 0960-0760 (ISSN-L)
- OpenAlex
- W2025894464
- Cited by
- 281
- References
- 191
- FWCI
- 16.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.